227 related articles for article (PubMed ID: 23376619)
1. Expression of coxsackievirus and adenovirus receptor (CAR)-Fc fusion protein in Pichia pastoris and characterization of its anti-coxsackievirus activity.
Zhang K; Yu H; Xie W; Xu Z; Zhou S; Huang C; Sheng H; He X; Xiong J; Qian G
J Biotechnol; 2013 Apr; 164(4):461-8. PubMed ID: 23376619
[TBL] [Abstract][Full Text] [Related]
2. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
[TBL] [Abstract][Full Text] [Related]
3. Soluble coxsackie- and adenovirus receptor (sCAR-Fc); a highly efficient compound against laboratory and clinical strains of coxsackie-B-virus.
Pinkert S; Dieringer B; Diedrich S; Zeichhardt H; Kurreck J; Fechner H
Antiviral Res; 2016 Dec; 136():1-8. PubMed ID: 27773751
[TBL] [Abstract][Full Text] [Related]
4. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
5. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
6. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
7. Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.
Werk D; Pinkert S; Heim A; Zeichhardt H; Grunert HP; Poller W; Erdmann VA; Fechner H; Kurreck J
Antiviral Res; 2009 Sep; 83(3):298-306. PubMed ID: 19591879
[TBL] [Abstract][Full Text] [Related]
8. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
9. Expression, purification and characterization of a human single-chain Fv antibody fragment fused with the Fc of an IgG1 targeting a rabies antigen in Pichia pastoris.
Wang DD; Su MM; Sun Y; Huang SL; Wang J; Yan WQ
Protein Expr Purif; 2012 Nov; 86(1):75-81. PubMed ID: 22982755
[TBL] [Abstract][Full Text] [Related]
10. Generation of a fusion protein of the extracellular domain of BR3 with the Fc fragment of human IgG1 (sBR3-Fc) in Pichia pastoris as an antagonist for BLyS.
Cao P; Zhang S; Fang Z; Huang H; Bai P; Zhang Q; Luo C
Appl Microbiol Biotechnol; 2008 Feb; 78(2):275-82. PubMed ID: 18189138
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
[TBL] [Abstract][Full Text] [Related]
12. [Construction and expression of a fusion protein containing extracellular domain of human Jagged1 and Fc fragment of human IgG1 in Pichia Pastoris].
Li GH; Kang ZJ; Huang SY; He F; Xu H; Zhang L; Wu YL; Niu XL; Ma CS; Han H; Liang YM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):910-4. PubMed ID: 18718088
[TBL] [Abstract][Full Text] [Related]
13. Interspecies differences in virus uptake versus cardiac function of the coxsackievirus and adenovirus receptor.
Freiberg F; Sauter M; Pinkert S; Govindarajan T; Kaldrack J; Thakkar M; Fechner H; Klingel K; Gotthardt M
J Virol; 2014 Jul; 88(13):7345-56. PubMed ID: 24741103
[TBL] [Abstract][Full Text] [Related]
14. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
[TBL] [Abstract][Full Text] [Related]
15. Effect of lovastatin on coxsackievirus B3 infection in human endothelial cells.
Werner B; Dittmann S; Funke C; Überla K; Piper C; Niehaus K; Horstkotte D; Farr M
Inflamm Res; 2014 Apr; 63(4):267-76. PubMed ID: 24316867
[TBL] [Abstract][Full Text] [Related]
16. Antiviral effect of Bosentan and Valsartan during coxsackievirus B3 infection of human endothelial cells.
Funke C; Farr M; Werner B; Dittmann S; Überla K; Piper C; Niehaus K; Horstkotte D
J Gen Virol; 2010 Aug; 91(Pt 8):1959-1970. PubMed ID: 20392896
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
[TBL] [Abstract][Full Text] [Related]
18. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
[TBL] [Abstract][Full Text] [Related]
19. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
Pinkert S; Westermann D; Wang X; Klingel K; Dörner A; Savvatis K; Grössl T; Krohn S; Tschöpe C; Zeichhardt H; Kotsch K; Weitmann K; Hoffmann W; Schultheiss HP; Spiller OB; Poller W; Fechner H
Circulation; 2009 Dec; 120(23):2358-66. PubMed ID: 19933937
[TBL] [Abstract][Full Text] [Related]
20. The Coxsackievirus and Adenovirus Receptor: Glycosylation and the Extracellular D2 Domain Are Not Required for Coxsackievirus B3 Infection.
Pinkert S; Röger C; Kurreck J; Bergelson JM; Fechner H
J Virol; 2016 Jun; 90(12):5601-5610. PubMed ID: 27030267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
